Dose-escalation study of the pharmacokinetics and pharmacodynamics of rivaroxaban in healthy elderly subjects

By Kubitza Dagmar   Becka Michael   Roth Angelika   Mueck Wolfgang  

Current Medical Research and Opinion, Vol. 24, Iss. 10, 2008-10 ,pp. : 2757-2765

Informa Healthcare

Access to resources Recommend Favorite

Effect of rifampin on the pharmacokinetics and pharmacodynamics of prasugrel in healthy male subjects

By Farid N. A.   Jakubowski J. A.   Payne C. D.   Li Y. G.   Jin Y.   Ernest C. S.   Winters K. J.   Brandt J. T.   Salazar D. E.   Small D. S.  

Current Medical Research and Opinion, Vol. 25, Iss. 8, 2009-08 ,pp. : 1821-1829

Informa Healthcare

Access to resources Recommend Favorite

Effect of the novel oral dipeptidyl peptidase IV inhibitor vildagliptin on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects

By He Yan-Ling   Sabo Ron   Riviere Gilles-Jacques   Sunkara Gangadhar   Leon Selene   Ligueros-Saylan Monica   Rosenberg Mitchell   Dole William P.   Howard Dan  

Current Medical Research and Opinion, Vol. 23, Iss. 5, 2007-05 ,pp. : 1131-1138

Informa Healthcare

Access to resources Recommend Favorite

A novel CRTH2 antagonist: Single‐ and multiple‐dose tolerability, pharmacokinetics, and pharmacodynamics of ACT‐453859 in healthy subjects

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 7, 2015-07 ,pp. : 787-797

John Wiley & Sons Inc

Access to resources Recommend Favorite

Pharmacokinetics, pharmacodynamics, safety, and tolerability of pradigastat, a novel diacylglycerol acyltransferase 1 inhibitor in overweight or obese, but otherwise healthy human subjects

By  

JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 55, Iss. 9, 2015-09 ,pp. : 1031-1041

John Wiley & Sons Inc

Access to resources Recommend Favorite